Company & Sponsor Intelligence
Federal University of Rio Grande do Sul
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials6
Recruiting0
Completed5
Countries1
Therapeutic footprint
adhdout_of_scopeparkinsons
Indexed studies
NCT00773916The Role of Adverse Environment Factors, Family Functioning and Parental Psychopathology in the Response to Treatment With Methylphenidate in Children and Adolescents With Attention Deficit/Hyperactivity Disorder
adhd · BrazilPHASE4
adhd · BrazilPHASE4
NCT03355521Effects of Nordic Walking in Parkinson Disease Patients
parkinsons · BrazilNA
parkinsons · BrazilNA
NCT00536419Impact of Attention Deficit/Hyperactivity Disorder and Substance Use Disorder on Motorcycle Traffic Accidents
adhd · BrazilPHASE4
adhd · BrazilPHASE4
NCT03370315Effects of a Dance and Walking Program for People With Parkinson's Disease
parkinsons · BrazilNA
parkinsons · BrazilNA
NCT05113524Effects of Dance on the Turning Characteristics of Patients With Parkinson's Disease
parkinsons · BrazilNA
parkinsons · BrazilNA
NCT04344210Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus
out_of_scope · BrazilNA
out_of_scope · BrazilNA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →